Hypocretin and human African trypanosomiasis

Sleep

Volumn 31, Issue 3, 2008, Pages 348-354

  Dauvilliers, Yves ^a   Bisser, Sylvie ^b,c   Chapotot, Florian ^d,e   Vatunga, Gedeao ^f   Cespuglio, Raymond ^g   Josenando, Téofilo ^f   Buguet, Alain ^g  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^d UNIVERSITY OF CHICAGO   (United States)

^e Human Factor Department   (France)

^f Istituto de Combate e Controlo Das Trypanossomiases   (Angola)

^g UNIVERSITÉ LYON 1   (France)

Author keywords

Hypersomnia; Hypocretin; Narcolepsy; REM sleep; Sleeping sickness; Trypanosome

Indexed keywords

OREXIN A;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CATAPLEXY; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL EVALUATION; CONTROLLED STUDY; DAYTIME SOMNOLENCE; FEMALE; HUMAN; INTERVIEW; MALE; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP WAKING CYCLE; TRYPANOSOMA;

EID: 42149112823     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/31.3.348     Document Type: Article

References (30)

1. Barrett MP. The rise and fall of sleeping sickness. Lancet 2006;367:1377-8.
2. Bouteille B, Oukem O, Bisser S, Dumas M. Treatment perspectives for human African trypanosomiasis. Fundam Clin Pharmacol 2003;17:171-81.
3. WHO. Control and Surveillance of African Trypanosomiasis. Report of a WHO Expert Committee. Technical Report Series no 881. Geneva, Switzerland, 1998, 114.
4. Simarro PP, Ruiz JA, Franco JR, Josenando T. Attitude towards CATT-positive individuals without parasitological confirmation in the African trypanosomiasis (T.b. gambiense) focus pf Quicama (Angola). Trop Med Int Health 1999;4:858-61.
5. Bisser S, Lejon V, Preux PM, Bouteille B, Stangheilini A, Jauberteau MO, Büscher P, Dumas M. Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci 2002;193:127-35.
6. Anonymous. Development and evaluation of new diagnostic tests for human African trypanosomiasis. Wkly Epidemiol Rec 2006;81:59-60.
7. Steverding D. A new initiative for the development of new diagnostic tests for human African trypanosomiasis. Kinetoplastid Biol Dis 2006;5:1-3.
8. Buguet A, Bisser S, Josenando T, Chapotot F, Cespuglio R. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness. Acta Trop 2005;93:107-17.
9. Buguet A, Bourdon L, Bouteille B, Cespuglio R, Vincendeau P, Radomski MW, Dumas M. The duality of sleeping sickness: focusing on sleep. Sleep Med Rev 2001;5:139-53.
10. Lhermitte J. La maladie du sommeil et les narcolepsies. XX° congrès des médecins aliénistes et neurologistes de France et des pays de langue française. Bruxelles, 1910 page 6-31.
11. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511.
12. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
13. Rechtschaffen A, Kales A. A Manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. NIH publications no204, Public Health Service, U.S. Govt. P.O, Washington, D.C.: 1968.
14. Littner MR, Kushida C, Wise M et al; Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113-21.
15. Mignot E, Lammers GJ, Ripley B et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
16. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol 2003;114: 2000-17.
17. Mignot E, Lin L, Finn L et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006; 129:1609-23.
18. Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74:1667-73.
19. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005;9:269-310.
20. Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL.Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 2007;130:1873-83.
21. Buguet A, Bert J, Tapie P, et al. Sleep-wake cycle in human African trypanosomiasis. J Clin Neurophysiol 1993;10:190-6.
22. Sabbah P, Brosset C, Imbert P, Bonardel G, Jeandel P, Briant JF. Human African trypanosomiasis: MRI. Neuroradiology 1997;39:708-10.
23. Braakman HM, van de Molengraft FJ, Hubert WW, Boerman DH. Lethal African trypanosomiasis in a traveller: MRI and neuropathology. Neurology 2006;66:1094-6
24. Kennedy PG. Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int J Parasitol 2006;36:505-12.
25. Gerashchenko D, Murillo-Rodriguez E, Lin L, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 2003;184:1010-6.
26. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007;130:1577-85.
27. Roky R, Obal F, Valatx JL, Bredow S, Fang J, Pagano L, Krueger JM. Prolactin and rapide eye movement sleep regulation. Sleep 1995;18:536-42.
28. Pentreath VW, Rees K, Owolabi OA, Philip KA, Doua F. The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans R Soc Trop Med Hyg 1990;84:795-9.
29. Buguet A. Is sleeping sickness a circadian disorder? The serotonergic hypothesis. Chronobiol Int 1999;16:477-89.
30. Ormerod WE, Hussein MSA. The ventricular ependyma of mice infected with Trypanosoma brucei. Trans Roy Soc Trop Med Hyg 1986;80:626-33.